Back to LBRX
GOLDMAN SACHS GROUP INC → LBRX
GOLDMAN SACHS GROUP INC LBRX Position History
LB Pharmaceuticals Inc • Healthcare
Quarters held
8
Latest value
$814K
Q3 2026
Peak value
$36.2M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $5.4M |
| Q4 2025 | $6.7M |
| Q4 2025 | $6.7M |
| Q1 2026 | $9M |
| Q2 2026 | $18.3M |
| Q2 2026 | $365K |
| Q3 2026 | $36.2M |
| Q3 2026 | $814K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $814K | 21.2K | — | — |
| Q3 2026 | $36.2M | 943.2K | — | — |
| Q2 2026 | $365K | 11.2K | — | — |
| Q2 2026 | $18.3M | 565.2K | — | — |
| Q1 2026 | $9M | 363.8K | — | — |
| Q4 2025 | $6.7M | 303.1K | — | — |
| Q4 2025 | $6.7M | 303.1K | — | — |
| Q3 2025 | $5.4M | 343.5K | — | — |
Other funds holding LBRX
$128.7M
$108.8M
$82.7M
$74.6M
$53.9M